Business Programme

Innovations in Pharmacology: The Intellectual Foundation of the Healthcare of the Future
Early Risk Medicine and Rehabilitation The development of new drugs not only ensures a quantum leap in disease treatment, but also promotes the development of new manufacturing processes and significantly influences the transformation of the entire patient care system by fundamentally shifting the therapeutic paradigm. Modern medical science has seen breakthrough developments in personalized medicine, particularly in cell therapy. Today, innovative CAR-T cell therapy is not only being successfully used in oncohematology, but is also steadily transitioning to the first clinical cases involving the immunoediting of malignant tumours, therapy for numerous autoimmune conditions, and treatment for type 1 diabetes, offering a chance to patients for whom standard treatments have proven ineffective. While this is not yet a new standard of therapy, these fundamental discoveries are being turned into clinical solutions that form the basis for new therapeutic strategies. Scientific research is focused on expanding the use of CAR-T therapy, reducing relapses and side effects, and increasing the length of remission. In what sectors is pharmaceutical innovation most rapidly developing today? How is the creation of new drugs changing approaches to patient care and leading to new standards in pharmaceutical manufacturing? What is the current state of cell therapy development, and what obstacles are limiting this progress? What regulatory tools are needed to actively introduce pharmaceutical innovations into clinical practice? What areas of medicine will have potential for CAR-T therapy in the near future?
How to Keep Your Heart Healthy
Early Risk Medicine and Rehabilitation Russia’s state guarantees programme for 2026–2028 has expanded its capabilities for the early diagnosis of cardiovascular risks, and work is under way to improve drug provisions for patients at high risk for vascular emergencies. An individual’s conscious behaviour can account for a significant portion of his/her success in combatting cardiovascular disease. The key ingredients for a healthy heart include timely preventive care and a healthy lifestyle: physical activity, nutrition, monitoring your indicators, avoiding bad habits, stress management, as well as a high level of patient engagement in the treatment process and strict adherence to any prescribed therapy. What innovations in cardiology are enhancing the effectiveness of the fight against circulatory diseases? What changes have been made to the state guarantees programme to provide free cardiac care? What measures are included in the government’s strategies to reduce risk factors? How can we ensure the public is committed to preventive care and a healthy lifestyle? How can we improve patient compliance and bolster the paradigm of collaboration between doctors and patients?
Diabetes under Control: Modern Solutions for Patients
Early Risk Medicine and Rehabilitation Advances in modern medicine are dramatically extending the lives of people with diabetes and improving their quality of life. Since 2023, Russia has prioritized the fight against diabetes with a special federal project that emphasizes strategies to prevent the progression of the disease with a focus on early stages and preclinical risks. Coordinated efforts by the government, medical community, and public sector need to focus on common goals in order to establish the systemic practice of implementing federal initiatives at the regional level. Which diagnostic technologies are most effective for the early detection of prediabetes and primary prevention? Which digital services and personalized monitoring technologies can improve the effectiveness of diabetes management, and how can they be integrated into patients’ daily lives to improve compliance? What educational and motivational practices can foster sustainable healthy lifestyle habits in people with risk factors? How can Russia develop a unified strategy for the prevention and early detection of diabetes for all regions of the country?
Preventing Behavioural Risk Factors for Non-communicable Diseases: The Efficacy of Restrictions and Prohibitions
Early Risk Medicine and Rehabilitation The growing prevalence of chronic diseases poses a challenge to the entire world and is forcing national healthcare systems to mobilize their resources to the maximum. The preventive measures that are being developed and introduced by Russia’s closest neighbours – countries of the former Soviet Union – go beyond medical prevention. State-sponsored approaches are often comprehensive and systemic, and involve the implementation of large-scale policies to reduce tobacco and alcohol consumption and combat harmful habits. How effective is this system of restrictions and prohibitions?
Personalized Medicine: An Individual Path to Good Health
Early Risk Medicine and Rehabilitation A key trend in modern healthcare is the shifting focus from diseases to patients themselves, with their unique needs, genetic characteristics, and lifestyle. This approach makes it possible to develop an individualized health trajectory, where prevention and risk management are based on personal data, the results of in-depth examinations, and genetic analysis, which help to identify individual risks at the earliest, preclinical stage. What are some of the effective mechanisms for integrating genetic screening data and biomarkers into daily preventive care? What technologies can be used to develop personalized recommendations for adjusting lifestyle, nutrition, and physical activity? What role can health resorts play in continuous health monitoring and promotion?
Rehabilitation of Winners: Reintegration into Life
Early Risk Medicine and Rehabilitation Modern rehabilitation medicine is a rapidly developing interdisciplinary field that integrates advances in clinical medicine, digital technologies, and various aspects of social and psychological disciplines within an evidence-based approach. Its goal is to create a continuous, personalized recovery system that aims to reintegrate patients into their former professional and social environments. One solution to these challenges is the establishment of high-tech rehabilitation centres for combat veterans, which take an interdisciplinary approach to treating both physical and psychological injuries. Sports rehabilitation, which borrows from professional sports methods, has become another highly effective field. These principles have proven effective not only for athletes, but for all patients, significantly reducing recovery times and enabling a return to a full, active life. What modern digital technologies have already been integrated into the rehabilitation process, and how are they influencing the personalization of people’s recovery? What criteria and biomarkers are being used to assess the success of a patient’s professional and social reintegration after completion of the active phase of treatment? What barriers are still hindering widespread access to rehabilitation for combat veterans, and what are some of the ways to overcome them in the compulsory health insurance system?